This three hour long virtual seminar will focus on the FDA regulation of energy drinks. It will cover regulatory requirements governing both conventional food products and dietary supplements, including rules governing product formulation, ingredient and product safety, and proper labeling. Attendees will also learn strategies for mitigating enforcement risk.
Why Should you Attend:
The US energy drink market has annual sales of more than $5 billion. Frequently, energy drinks may include a combination of caffeine, sugar, guarana, ginseng or taurine. For regulatory purposes, these products are regulated either as conventional foods or dietary supplements. Recently, the FDA has seen an increase in the number of reported adverse events and has taken steps to mitigate the potential risks to adolescents and the public generally.
This webinar will examine the FDA’s current regulation of energy drinks and the agency’s position on the marketing and sale of such products. It will analyze the conventional food vs. dietary supplement regulatory debate, and will discuss the requirements applicable to both. FDA’s rules governing product formulation, ingredient and product safety, and proper labeling will be covered. The use of caffeine in alcoholic beverages will also be analyzed. Finally, attendees will be provided with recommendations for complying with the FDA’s regulatory requirements and strategies for mitigating enforcement risk.
Learning Objectives:
Upon completion of this webinar, attendees will:
Areas covered in this webinar:
Who Will Benefit:
Instructor Profile:
Karl Nobert, is a Food and Drug Regulatory Attorney in Washington, DC. He regularly provides FDA regulatory advice and counseling to domestic and international food and beverage manufacturers among others. He has served as a regulatory consultant to several large food and drink companies on issues including proper labeling, ingredient safety, marketing and advertising, manufacturing, cGMPs, packaging, distribution and FDA regulatory compliance generally. He has also prepped and readied both U.S. and foreign companies for FDA facility compliance inspections. He frequently presents and has published on such topics.